[Data] Integrated simulation software for bio and antibody drug discovery.

Schrödinger, Inc. will be exhibiting at the 2nd Annual Meeting of the Japanese Society for Antibody Research. Venue: Laika Nankoku Hall (Kagoshima) Dates: December 1 (Friday) - 3 (Sunday) 【Oral Presentation】 Date and Time: December 3 (Sunday) 15:10 - 15:35 Title: The Role and Impact of Computational Modeling in the Design and Development of Antibody-based Therapeutics Presenter: Eliud Oloo, Schrödinger, Inc. 【Poster Presentation】 Date and Time: December 2 (Saturday) 18:20 - 19:10 Title: Physics-based antibody analysis and design: Modeling of antigen-antibody complexes with disordered epitopes/very long CDR-H3 loops Presenter: Shuu Ichihara (Schrödinger, Inc.)

Schrödinger, Inc. will be exhibiting at the 23rd Annual Meeting of the Japanese Society for Protein Science. Utilizing computational chemistry techniques based on the first principles of physics, which are employed by major pharmaceutical companies worldwide, we enable advanced drug design based on protein structural information. - Antibody 3D modeling using the integrated solution "BioLuminate" for biologics and antibody drug discovery - Prediction of antigen-antibody complex structures using protein-protein docking - Affinity and stability predictions using Free Energy Perturbation (FEP) methods Additionally, we will hold a luncheon seminar on Thursday, July 6, starting at 11:50. 【Luncheon Seminar Date and Location】 Date: Thursday, July 6, 11:50 - 12:40 Venue: 3rd Floor, Room C 【Program】 Schrödinger's approach to physics-based antibody analysis and design: dealing with disordered epitopes and very long CDR H3 loop Shu Ichihara (Schrödinger, Inc.)